Dynavox Group AB (publ) (STO:DYVOX)
Sweden · Delayed Price · Currency is SEK 125.50
-3.60 (-2.79%)
At close: Aug 12, 2025
Model N Revenue
Dynavox Group AB had revenue of 603.00M SEK in the quarter ending June 30, 2025, with 26.68% growth. This brings the company's revenue in the last twelve months to 2.25B, up 25.03% year-over-year. In the year 2024, Dynavox Group AB had annual revenue of 1.97B with 22.24% growth.
Revenue (ttm)
2.25B
Revenue Growth
+25.03%
P/S Ratio
5.98
Revenue / Employee
2.46M
Employees
855
Market Cap
13.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.97B | 358.80M | 22.24% |
| Dec 31, 2023 | 1.61B | 396.90M | 32.63% |
| Dec 31, 2022 | 1.22B | 344.80M | 39.56% |
| Dec 31, 2021 | 871.60M | -23.60M | -2.64% |
| Dec 31, 2020 | 895.20M | -13.60M | -1.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.97B |
| Sectra AB | 3.31B |
| Getinge AB | 35.50B |
| Medicover AB | 25.22B |
| Camurus AB | 2.27B |
| Asker Healthcare Group AB | 15.88B |
| BioArctic AB | 1.52B |
| Bonesupport Holding AB | 1.06B |